SCHEMBL7259014

SCHEMBL7259014

CC(=O)CC(c1ccc(Cl)cc1)N(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.46
OPRM1 P35372 1/20 0.43
AOC3 Q16853 1/20 0.42
GABBR2 O75899 3/20 0.41
GABBR1 Q9UBS5 3/20 0.41
CYP2C9 P11712 3/20 0.41
LMNA P02545 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
NFKB1 P19838 1/20 0.41
DRD3 P35462 1/20 0.41
BLM P54132 1/20 0.41
CYP1A2 P05177 1/20 0.41
THRB P10828 1/20 0.41
TSHR P16473 1/20 0.41
POLB P06746 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4567237 0.86 GABBR2 (0.53) BRD4OPRM1AOC3GABBR2GABBR1
SCHEMBL7496510 0.82 OPRM1 (0.43) OPRM1AOC3LMNAKMT2AFFAR1
SCHEMBL12861359 0.82 TACR1 (0.40) OPRM1MEN1KMT2A
SCHEMBL8605476 0.81 CHRNB2 (0.53) OPRM1LMNAMEN1KMT2A
SCHEMBL12861292 0.81 ALDH1A1 (0.57) OPRM1AOC3MEN1KMT2A
SCHEMBL12861282 0.80 OPRM1 (0.49) OPRM1AOC3MEN1KMT2A
SCHEMBL16795852 0.80 MAOA (0.42) BRD4AOC3GABBR2GABBR1CYP2C9
SCHEMBL12861378 0.79 PTGS2 (0.47) OPRM1MEN1KMT2AFFAR1
SCHEMBL5321171 0.79 HTT (0.44) CYP2C9LMNACYP2D6CYP2C19CYP3A4
SCHEMBL12861372 0.79 CHRNB2 (0.36) OPRM1CYP2C19KMT2ACYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110039714-A1 Probes, Systems, and Methods for Drug Discovery VTVX HOLDINGS I LLC 2011-02-17 US disclosed
WO-2003104216-A1 UROTENSIN II RECEPTOR MODULATORS ACADIA PHARMACEUTICALS INC. (US) 2003-12-18 WO disclosed